GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Cyclically Adjusted PS Ratio

Ibex Technologies (TSXV:IBT) Cyclically Adjusted PS Ratio : 5.76 (As of Jun. 07, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Cyclically Adjusted PS Ratio?

As of today (2024-06-07), Ibex Technologies's current share price is C$1.44. Ibex Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was C$0.25. Ibex Technologies's Cyclically Adjusted PS Ratio for today is 5.76.

The historical rank and industry rank for Ibex Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSXV:IBT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.33   Med: 1.18   Max: 5.76
Current: 5.71

During the past years, Ibex Technologies's highest Cyclically Adjusted PS Ratio was 5.76. The lowest was 0.33. And the median was 1.18.

TSXV:IBT's Cyclically Adjusted PS Ratio is ranked worse than
50.89% of 505 companies
in the Biotechnology industry
Industry Median: 5.46 vs TSXV:IBT: 5.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ibex Technologies's adjusted revenue per share data for the three months ended in Jan. 2024 was C$0.078. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$0.25 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ibex Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Ibex Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Cyclically Adjusted PS Ratio Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 1.48 1.51 1.66 4.82

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 3.64 4.82 4.01 4.44

Competitive Comparison of Ibex Technologies's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Ibex Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Cyclically Adjusted PS Ratio falls into.



Ibex Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ibex Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.44/0.25
=5.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ibex Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Ibex Technologies's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=0.078/125.0724*125.0724
=0.078

Current CPI (Jan. 2024) = 125.0724.

Ibex Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201404 0.046 98.920 0.058
201407 0.047 99.315 0.059
201410 0.025 99.473 0.031
201501 0.040 98.209 0.051
201504 0.031 99.710 0.039
201507 0.047 100.579 0.058
201510 0.057 100.500 0.071
201601 0.058 100.184 0.072
201604 0.030 101.370 0.037
201607 0.035 101.844 0.043
201610 0.061 102.002 0.075
201701 0.073 102.318 0.089
201704 0.045 103.029 0.055
201707 0.059 103.029 0.072
201710 0.048 103.424 0.058
201801 0.043 104.056 0.052
201804 0.066 105.320 0.078
201807 0.051 106.110 0.060
201810 0.050 105.952 0.059
201901 0.058 105.557 0.069
201904 0.026 107.453 0.030
201907 0.038 108.243 0.044
201910 0.044 107.927 0.051
202001 0.041 108.085 0.047
202004 0.054 107.216 0.063
202007 0.058 108.401 0.067
202010 0.047 108.638 0.054
202101 0.053 109.192 0.061
202104 0.059 110.851 0.067
202107 0.052 112.431 0.058
202110 0.080 113.695 0.088
202201 0.090 114.801 0.098
202204 0.078 118.357 0.082
202207 0.070 120.964 0.072
202210 0.077 121.517 0.079
202301 0.069 121.596 0.071
202304 0.076 123.571 0.077
202307 0.071 124.914 0.071
202310 0.076 125.310 0.076
202401 0.078 125.072 0.078

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ibex Technologies  (TSXV:IBT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ibex Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines